Yuanfeng Xin

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Apoptotic bodies derived from human umbilical cord mesenchymal stem cells improve recovery from myocardial infarction in swine.

Apoptotic bodies derived from human umbilical cord mesenchymal stem cells improve recovery from myocardial infarction in swine.

Journal: Autophagy
Published: January 20, 2026

PINCH proteins orchestrate vascular mural cell homeostasis through integrated signaling and transcriptional networks.

PINCH proteins orchestrate vascular mural cell homeostasis through integrated signaling and transcriptional networks.

Journal: Angiogenesis
Published: November 27, 2025

Correction: Intramyocardial injected human umbilical cord-derived mesenchymal stem cells (HucMSCs) contribute to the recovery of cardiac function and the migration of CD4+ T cells into the infarcted heart via CCL5/CCR5 signaling.

Correction: Intramyocardial injected human umbilical cord-derived mesenchymal stem cells (HucMSCs) contribute to the recovery of cardiac function and the migration of CD4+ T cells into the infarcted heart via CCL5/CCR5 signaling.

Journal: Stem cell research & therapy
Published: November 18, 2025

PRIME-HFrEF Trial: a randomized, double-blind, multi-dose umbilical cord-derived mesenchymal stem cell regimen for heart failure.

PRIME-HFrEF Trial: a randomized, double-blind, multi-dose umbilical cord-derived mesenchymal stem cell regimen for heart failure.

Journal: Signal transduction and targeted therapy
Published: September 19, 2025

Corrigendum to "Repeat administration of human umbilical cord mesenchymal stem cells improves left ventricular diastolic function in mice with heart failure with preserved ejection fraction" [Biochem. Biophys. Res. Commun. 737 (2024) 150525].

Corrigendum to "Repeat administration of human umbilical cord mesenchymal stem cells improves left ventricular diastolic function in mice with heart failure with preserved ejection fraction" [Biochem. Biophys. Res. Commun. 737 (2024) 150525].

Journal: Biochemical and biophysical research communications
Published: July 29, 2025

Apoptotic bodies derived from human umbilical cord mesenchymal stem cells improve recovery from myocardial infarction in swine.

Apoptotic bodies derived from human umbilical cord mesenchymal stem cells improve recovery from myocardial infarction in swine.

Journal: Autophagy
Published: July 20, 2025

Identification of the crucial roles of BAXhigh NK cells in human derived mesenchymal stem cell therapy for chronic heart failure patients.

Identification of the crucial roles of BAXhigh NK cells in human derived mesenchymal stem cell therapy for chronic heart failure patients.

Journal: Pathology, research and practice
Published: March 03, 2025

Repeat administration of human umbilical cord mesenchymal stem cells improves left ventricular diastolic function in mice with heart failure with preserved ejection fraction.

Repeat administration of human umbilical cord mesenchymal stem cells improves left ventricular diastolic function in mice with heart failure with preserved ejection fraction.

Journal: Biochemical and biophysical research communications
Published: July 25, 2024

A prospective randomized controlled study of multi-intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure and reduced ejection fraction (PRIME-HFrEF) trial: Rationale and design.

A prospective randomized controlled study of multi-intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure and reduced ejection fraction (PRIME-HFrEF) trial: Rationale and design.

Journal: Contemporary clinical trials communications
Published: April 21, 2024

Single cell RNA-seq identifies a FOS/JUN-related monocyte signature associated with clinical response of heart failure patients with mesenchymal stem cell therapy.

Single cell RNA-seq identifies a FOS/JUN-related monocyte signature associated with clinical response of heart failure patients with mesenchymal stem cell therapy.

Journal: Aging
Published: October 16, 2023

Prognostic role of tissue plasminogen activator in coronary artery disease with or without aortic valve sclerosis.

Prognostic role of tissue plasminogen activator in coronary artery disease with or without aortic valve sclerosis.

Journal: ESC heart failure
Published: January 13, 2023

Ginsenoside Rg1 Protects against Cardiac Remodeling in Heart Failure via SIRT1/PINK1/Parkin-Mediated Mitophagy.

Ginsenoside Rg1 Protects against Cardiac Remodeling in Heart Failure via SIRT1/PINK1/Parkin-Mediated Mitophagy.

Journal: Chemistry & biodiversity
Published: August 03, 2022
Showing 1-12 of 17

Last Updated: 09/26/2026